Thomas A. Bayer
AuthID: R-00H-BAY
1
TÃTULO: Chronic exposure to a synthetic cannabinoid improves cognition and increases locomotor activity in Tg4-42 Alzheimer's disease mice
AUTORES: Ott, Frederik W.; Sichler, Marius E.; Bouter, Caroline; Enayati, Marzieh; Wiltfang, Jens; Bayer, Thomas A.; Beindorff, Nicola; Low, Maximilian J.; Bouter, Yvonne;
PUBLICAÇÃO: 2025, FONTE: JOURNAL OF ALZHEIMERS DISEASE REPORTS, VOLUME: 9
AUTORES: Ott, Frederik W.; Sichler, Marius E.; Bouter, Caroline; Enayati, Marzieh; Wiltfang, Jens; Bayer, Thomas A.; Beindorff, Nicola; Low, Maximilian J.; Bouter, Yvonne;
PUBLICAÇÃO: 2025, FONTE: JOURNAL OF ALZHEIMERS DISEASE REPORTS, VOLUME: 9
INDEXADO EM: 
WOS 
CrossRef
WOS CrossRef2
TÃTULO: N-terminal heterogeneity of parenchymal and vascular amyloid-beta deposits in Alzheimer's disease Full Text
AUTORES: Zampar, S; Klafki, HW; Sritharen, K; Bayer, TA; Wiltfang, J; Rostagno, A; Ghiso, J; Miles, LA; Wirths, O;
PUBLICAÇÃO: 2020, FONTE: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
AUTORES: Zampar, S; Klafki, HW; Sritharen, K; Bayer, TA; Wiltfang, J; Rostagno, A; Ghiso, J; Miles, LA; Wirths, O;
PUBLICAÇÃO: 2020, FONTE: NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
INDEXADO EM: 
Scopus WOS
Scopus WOS